Mazor Surgical Technologies Ltd. has received approval from the ethical committee (Helsinki) of a leading hospital in Israel (Sheba Medical Center) to begin human clinical trial with the Mazor proprietary GO-LIF™ (Guided Oblique Lumbar Interbody Fusion) surgical procedure and implants. This approval allows surgeons to use GO-LIF procedure and Mazor proprietary screws in patients undergoing spinal fixation surgery. Mazor expects this study to demonstrate that the GO-LIF procedure is safe and efficacious leading to improve surgical outcome compared to current procedures. The GO-LIF procedure is an innovative spine surgical procedure developed by Mazor and in partnership with the Cleveland Clinic Foundation, according to the strategic agreement signed in April 2008. This procedure enables spinal fixation by insertion of proprietary GO-LIF implants into the patient’s spine in a minimally invasive surgical technique and accurate guidance enabled by SpineAssist®, Mazor’s miniature robotic device. The GO-LIF clinical study will include additional surgeons and hospitals in 8 medical centers in Israel, Germany and later on in the US, pending additional Helsinki and IRB approvals.
Mazor Surgical Technologies was founded in 2001, and is dedicated to the research, development, production, marketing and sales of innovative medical devices for surgical procedures. Mazor’s proprietary technology enables a safer surgical environment for patients, surgeons and OR staff, by utilizing miniature robotic, imaging and implant technologies. Mazor’s corporate headquarters is located in Caesarea, Israel and regional offices are located in the Atlanta and Germany. Mazor Joined AICC in 2005 and Nancy Sousa, Mazor’s Chief Operating Oficer is a member of AICC Executive Committee, Board of Directors, and Medical Committee.